Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs

Clinical trial NCT04077957 · UNKNOWN

Trial details

NCT number: NCT04077957
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Ankylosing Spondylitis Spondyloarthritis

Start date: 2019-10-07
Primary completion: 2021-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.